S
Scope Fluidics SA
WSE:SCP
Scope Fluidics SA
WSE:SCP
Price:
140
PLN
0.57%
Market Closed
Market Cap:
zł443.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Scope Fluidics SA
WSE:SCP
|
PL |
|
Bancolombia SA
NYSE:CIB
|
CO |
|
P
|
Pomi Frutas SA - em Recuperacao Judicial
BOVESPA:FRTA3
|
BR |
|
Ministop Co Ltd
TSE:9946
|
JP |
|
N
|
NZME Ltd
ASX:NZM
|
NZ |
|
National Bank Holdings Corp
NYSE:NBHC
|
US |
|
BBX Minerals Ltd
ASX:BBX
|
AU |
|
Shenzhen Huijie Group Co Ltd
SZSE:002763
|
CN |
|
N G Industries Ltd
BSE:530897
|
IN |
|
E
|
EOFlow Co Ltd
KOSDAQ:294090
|
KR |
|
Kose Corp
OTC:KSRYY
|
JP |
|
Zhejiang Hisoar Pharmaceutical Co Ltd
SZSE:002099
|
CN |
|
C
|
China Shineway Pharmaceutical Group Ltd
OTC:CSWYF
|
CN |
|
E
|
ELK-Desa Resources Bhd
KLSE:ELKDESA
|
MY |
|
Health Italia SpA
MIL:HI
|
IT |
|
G
|
Generix Group SA
LSE:0JAW
|
FR |
|
Alpine Summit Energy Partners Inc
XTSX:ALPS.U
|
CA |
|
Belimo Holding AG
SIX:BEAN
|
CH |
|
CMOC Group Ltd
SSE:603993
|
CN |
|
Surge Battery Metals Inc
XTSX:NILI
|
CA |
Multiples-Based Value
The Multiples-Based Value for Scope Fluidics SA (SCP) under the Base Case is hidden PLN. Compared with the current market price of 140 PLN, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SCP Multiples-Based Value
LOCKED
Multiples Across Competitors
SCP Competitors Multiples
Scope Fluidics SA Competitors
Scope Fluidics SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| PL |
S
|
Scope Fluidics SA
WSE:SCP
|
443.8m PLN | 618.1 | 8.1 | -8.6 | -8.2 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
176.4B USD | 4 | 27 | 15.5 | 21.3 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
166.3B USD | 16.5 | 58.2 | 44.1 | 54.2 | |
| US |
|
Stryker Corp
NYSE:SYK
|
130.5B USD | 5.2 | 40.2 | 20.5 | 24.8 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.8B USD | 3.2 | 24.2 | 13.4 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
95.8B USD | 4.8 | 33.1 | 19.6 | 26.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.2B EUR | 1.9 | 20.5 | 11.4 | 16.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.3B USD | 10.8 | 43.7 | 31 | 34.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.4B USD | 7.5 | 42.3 | 23 | 25.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.3B USD | 2 | 25.2 | 10 | 16.9 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
33.5B USD | 1.6 | 16.1 | 11.5 | 14 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
